Exact Mass: 544.3764

Exact Mass Matches: 544.3764

Found 90 metabolites which its exact mass value is equals to given mass value 544.3764, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Ganoderic acid Mj

(2Z)-5-(acetyloxy)-6-{5-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


Ganoderic acid Mj is found in mushrooms. Ganoderic acid Mj is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mj is found in mushrooms.

   

Ganoderic acid Mi

(2Z)-6-[5-(acetyloxy)-12-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


Ganoderic acid Mi is found in mushrooms. Ganoderic acid Mi is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Ganoderic acid Mi is found in mushrooms.

   

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C33H52O6 (544.3764)


DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoate

C33H52O6 (544.3764)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3764)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3764)


DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoate

C33H52O6 (544.3764)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3764)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3764)


DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C33H52O6 (544.3764)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3764)


DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3764)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3764)


DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

(2S)-2-Hydroxy-3-(octanoyloxy)propyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C33H52O6 (544.3764)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Methyl 2-acetyltormentate

Methyl 2-acetyltormentate

C33H52O6 (544.3764)


   

22-Acetoxy-3alpha-hydroxy-7alpha-methoxylanosta-8,24E-dien-26-oic acid

22-Acetoxy-3alpha-hydroxy-7alpha-methoxylanosta-8,24E-dien-26-oic acid

C33H52O6 (544.3764)


   

16beta-methoxyalisol B 23-acetate|16beta-Methoxyalisol B monoacetate

16beta-methoxyalisol B 23-acetate|16beta-Methoxyalisol B monoacetate

C33H52O6 (544.3764)


   

3alpha-acetoxy-21R-methoxy-17alpha-20S-21,23R-epoxyapotirucall-14,25-dien-7alpha,24R-diol|chisopanin C

3alpha-acetoxy-21R-methoxy-17alpha-20S-21,23R-epoxyapotirucall-14,25-dien-7alpha,24R-diol|chisopanin C

C33H52O6 (544.3764)


   

hippuristerone B

hippuristerone B

C33H52O6 (544.3764)


   

3beta-acetoxy-12beta-methoxy-7,8-dihydroholothurinogenin

3beta-acetoxy-12beta-methoxy-7,8-dihydroholothurinogenin

C33H52O6 (544.3764)


   

methyl tormentate-3-acetate

methyl tormentate-3-acetate

C33H52O6 (544.3764)


   

23-acetoxyimberbic acid 29-methyl ester

23-acetoxyimberbic acid 29-methyl ester

C33H52O6 (544.3764)


   

phyllofoliaspongin

phyllofoliaspongin

C33H52O6 (544.3764)


   

(2alpha,3alpha)-2,29-dihydroxy-3,23-[(1,1-dimethylmethylene)dioxy]olean-12-en-28-oic acid|stachlic acid B

(2alpha,3alpha)-2,29-dihydroxy-3,23-[(1,1-dimethylmethylene)dioxy]olean-12-en-28-oic acid|stachlic acid B

C33H52O6 (544.3764)


   

cavalerol J|methyl (3beta,6beta,11beta,17epsilon,21beta)-6-(acetyloxy)-3,11-dihydroxyhop-22(29)-en-24-oate|methyl 6beta-(acetyloxy)-3beta,11beta-dihydroxy-21alphaH-hop-22(29)-en-24-oate

cavalerol J|methyl (3beta,6beta,11beta,17epsilon,21beta)-6-(acetyloxy)-3,11-dihydroxyhop-22(29)-en-24-oate|methyl 6beta-(acetyloxy)-3beta,11beta-dihydroxy-21alphaH-hop-22(29)-en-24-oate

C33H52O6 (544.3764)


   

2-Ac,Me ester-2,3,23-(2alpha,3beta)-Trihydroxy-12-oleanen-28-oic acid

2-Ac,Me ester-2,3,23-(2alpha,3beta)-Trihydroxy-12-oleanen-28-oic acid

C33H52O6 (544.3764)


   

2alpha-acetoxy-3beta,24-epoxy-3alpha-hydroxy-D:A-friedooleanan-29-oic acid methyl ester

2alpha-acetoxy-3beta,24-epoxy-3alpha-hydroxy-D:A-friedooleanan-29-oic acid methyl ester

C33H52O6 (544.3764)


   

methyl 2-acetylasiatate

methyl 2-acetylasiatate

C33H52O6 (544.3764)


   

11α-Hemiglutaryloxy-1,25-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,11R)-11-hemiglutaryloxy-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C33H52O6 (544.3764)


   

Ganoderic acid Mi

(2Z)-6-[5-(acetyloxy)-12-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

Ganoderic acid Mj

(2Z)-5-(acetyloxy)-6-{5-hydroxy-9-methoxy-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

11alpha-Hemiglutaryloxy-1,25-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,11R)-11-hemiglutaryloxy-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol

C33H52O6 (544.3764)


   

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

DG(8:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C33H52O6 (544.3764)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/8:0/0:0)

C33H52O6 (544.3764)


   

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

DG(8:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C33H52O6 (544.3764)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/8:0)

C33H52O6 (544.3764)


   

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

DG(8:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C33H52O6 (544.3764)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/8:0/0:0)

C33H52O6 (544.3764)


   

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

DG(8:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C33H52O6 (544.3764)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/8:0)

C33H52O6 (544.3764)


   

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

DG(8:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C33H52O6 (544.3764)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/8:0/0:0)

C33H52O6 (544.3764)


   

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

DG(8:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C33H52O6 (544.3764)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/8:0)

C33H52O6 (544.3764)


   

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

DG(8:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C33H52O6 (544.3764)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/8:0/0:0)

C33H52O6 (544.3764)


   

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

DG(8:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C33H52O6 (544.3764)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/8:0)

C33H52O6 (544.3764)


   

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

DG(8:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C33H52O6 (544.3764)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/8:0/0:0)

C33H52O6 (544.3764)


   

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

DG(8:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C33H52O6 (544.3764)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/8:0)

C33H52O6 (544.3764)


   

TG(30:5)

TG(6:0_10:4_14:1)

C33H52O6 (544.3764)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ST 27:3;O;Hex

ST 27:3;O;Hex

C33H52O6 (544.3764)


   

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C33H52O6 (544.3764)


   

(2z)-5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

(2z)-5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate

1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate

C33H52O6 (544.3764)


   

16β-methoxyalisol B monoacetate

NA

C33H52O6 (544.3764)


{"Ingredient_id": "HBIN001838","Ingredient_name": "16\u03b2-methoxyalisol B monoacetate","Alias": "NA","Ingredient_formula": "C33H52O6","Ingredient_Smile": "NA","Ingredient_weight": "544.76","OB_score": "32.42724106","CAS_id": "115333-90-9","SymMap_id": "SMIT03365","TCMID_id": "NA","TCMSP_id": "MOL000849","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

alisol b; 23-ac,16β-methoxy

NA

C33H52O6 (544.3764)


{"Ingredient_id": "HBIN015148","Ingredient_name": "alisol b; 23-ac,16\u03b2-methoxy","Alias": "NA","Ingredient_formula": "C33H52O6","Ingredient_Smile": "NA","Ingredient_weight": "544.76","OB_score": "NA","CAS_id": "115333-90-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7029","PubChem_id": "NA","DrugBank_id": "NA"}

   

16-hydroxy-11-(hydroxymethyl)-2,2,4a,6a,6b,11,14b-heptamethyl-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

16-hydroxy-11-(hydroxymethyl)-2,2,4a,6a,6b,11,14b-heptamethyl-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C33H52O6 (544.3764)


   

5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

5-(acetyloxy)-6-{7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7r,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7r,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

2-acetyl-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-12-oxo-dodecahydro-1h-chrysen-3-yl 3-hydroxy-4-methylpentanoate

2-acetyl-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-12-oxo-dodecahydro-1h-chrysen-3-yl 3-hydroxy-4-methylpentanoate

C33H52O6 (544.3764)


   

4-hydroxy-1-[5-(1-hydroxy-2-methylprop-2-en-1-yl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

4-hydroxy-1-[5-(1-hydroxy-2-methylprop-2-en-1-yl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H52O6 (544.3764)


   

(1s,2s,3r,4as,4br,6as,7s,10as,10br,12as)-2-acetyl-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-12-oxo-dodecahydro-1h-chrysen-3-yl (3r)-3-hydroxy-4-methylpentanoate

(1s,2s,3r,4as,4br,6as,7s,10as,10br,12as)-2-acetyl-7-ethyl-1-formyl-4b,7,10a,12a-tetramethyl-12-oxo-dodecahydro-1h-chrysen-3-yl (3r)-3-hydroxy-4-methylpentanoate

C33H52O6 (544.3764)


   

(1s,3r)-3-[(2s,3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate

(1s,3r)-3-[(2s,3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate

C33H52O6 (544.3764)


   

6-[7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

6-[7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

(2e,6r)-6-[(1r,3s,3ar,4r,5as,7r,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2e,6r)-6-[(1r,3s,3ar,4r,5as,7r,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H52O6 (544.3764)


   

(4ar,4br,6ar,6bs,8ar,11r,12as,14ar,14br,16r,16as)-16-hydroxy-11-(hydroxymethyl)-2,2,4a,6a,6b,11,14b-heptamethyl-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

(4ar,4br,6ar,6bs,8ar,11r,12as,14ar,14br,16r,16as)-16-hydroxy-11-(hydroxymethyl)-2,2,4a,6a,6b,11,14b-heptamethyl-4h,4bh,5h,6h,7h,8h,9h,10h,12h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylic acid

C33H52O6 (544.3764)


   

methyl (2r,4as,6as,6br,8ar,9r,10s,12s,12ar,12bs,14bs)-9-[(acetyloxy)methyl]-10,12-dihydroxy-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylate

methyl (2r,4as,6as,6br,8ar,9r,10s,12s,12ar,12bs,14bs)-9-[(acetyloxy)methyl]-10,12-dihydroxy-2,4a,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-2-carboxylate

C33H52O6 (544.3764)


   

methyl (3r,3as,5ar,5br,7r,7ar,8r,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,8,11a,13b-pentamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-8-carboxylate

methyl (3r,3as,5ar,5br,7r,7ar,8r,9s,11ar,11br,12s,13ar,13bs)-7-(acetyloxy)-9,12-dihydroxy-5a,5b,8,11a,13b-pentamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-8-carboxylate

C33H52O6 (544.3764)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1r)-1-hydroxy-2-methylprop-2-en-1-yl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C33H52O6 (544.3764)


   

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-(acetyloxy)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

methyl (1r,2r,4as,6as,6br,8ar,10r,11r,12ar,12br,14bs)-10-(acetyloxy)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C33H52O6 (544.3764)


   

methyl 7-(acetyloxy)-9,12-dihydroxy-5a,5b,8,11a,13b-pentamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-8-carboxylate

methyl 7-(acetyloxy)-9,12-dihydroxy-5a,5b,8,11a,13b-pentamethyl-3-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-8-carboxylate

C33H52O6 (544.3764)


   

(3r,4r,5s)-5-[(1r,3'r,3ar,3bs,5ar,9ar,9br,11ar)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-2,3,4-trimethylpentan-2-yl acetate

(3r,4r,5s)-5-[(1r,3'r,3ar,3bs,5ar,9ar,9br,11ar)-3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl]-5-(acetyloxy)-2,3,4-trimethylpentan-2-yl acetate

C33H52O6 (544.3764)


   

methyl 10-(acetyloxy)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

methyl 10-(acetyloxy)-1,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C33H52O6 (544.3764)


   

(2z)-6-[7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2z)-6-[7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

(2e,5s,6s)-6-[(1r,3ar,4r,5ar,7r,9as,11ar)-7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

(2e,5s,6s)-6-[(1r,3ar,4r,5ar,7r,9as,11ar)-7-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(acetyloxy)-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

(2e,6r)-6-[(1r,3s,3ar,4r,5ar,7s,9as,11ar)-7-(acetyloxy)-3-hydroxy-4-methoxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C33H52O6 (544.3764)


   

methyl 11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

methyl 11-(acetyloxy)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C33H52O6 (544.3764)


   

5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2,3,4-trimethylpentan-2-yl acetate

5-{3',9a,11a-trimethyl-7-oxo-dodecahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxiran]-3'-yl}-5-(acetyloxy)-2,3,4-trimethylpentan-2-yl acetate

C33H52O6 (544.3764)